Page last updated: 2024-11-02

phenoxybenzamine and Metabolic Diseases

phenoxybenzamine has been researched along with Metabolic Diseases in 3 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lambotte, L1
Rocmans, P1
Ettinger, PO1
Oldewurtel, HA1
Dzindzio, B1
Sethi, V1
Regan, TJ1
Savoie, LL1

Other Studies

3 other studies available for phenoxybenzamine and Metabolic Diseases

ArticleYear
[Toxi-infectious shock].
    Acta chirurgica Belgica, 1973, Volume: 72, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Chlorpromazine; Digitalis G

1973
Glucose intolerance in nonischemic cardiac disease. Role of cardiac output and adrenergic function.
    Circulation, 1971, Volume: 43, Issue:6

    Topics: Adolescent; Adult; Aged; Cardiac Output; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Female; Glu

1971
[Role of antikaliuretics and catecholamines in the prevention of cardiac necroses of metabolic origin].
    Pathologia Europaea, 1971, Volume: 6, Issue:4

    Topics: Adrenal Cortex Hormones; Amiloride; Animals; Catecholamines; Digitoxin; Diuretics; Epinephrine; Hear

1971